Free Trial

Truist Financial Issues Positive Forecast for National Health Investors (NYSE:NHI) Stock Price

National Health Investors logo with Finance background

Key Points

  • Truist Financial has raised the price target for National Health Investors (NHI) from $77.00 to $81.00, indicating a potential upside of 9.12% from the current stock price.
  • National Health Investors reported an EPS of $1.22 for the last quarter, exceeding the consensus estimate of $1.16.
  • Multiple analysts have given NHI ratings ranging from "hold" to "strong buy," with an average rating of Moderate Buy and a consensus price target of $85.40.
  • Looking to export and analyze National Health Investors data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

National Health Investors (NYSE:NHI - Free Report) had its price objective increased by Truist Financial from $77.00 to $81.00 in a research note released on Friday,Benzinga reports. They currently have a buy rating on the real estate investment trust's stock.

A number of other equities analysts also recently weighed in on NHI. Wedbush raised shares of National Health Investors to a "strong-buy" rating in a report on Wednesday, July 2nd. KeyCorp raised shares of National Health Investors from a "sector weight" rating to an "overweight" rating and set a $80.00 price target on the stock in a report on Thursday, July 10th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, National Health Investors currently has a consensus rating of "Buy" and a consensus target price of $85.40.

View Our Latest Report on NHI

National Health Investors Stock Up 1.6%

NHI traded up $1.1670 during mid-day trading on Friday, reaching $76.0570. 168,758 shares of the stock were exchanged, compared to its average volume of 248,607. The company has a debt-to-equity ratio of 0.75, a quick ratio of 10.91 and a current ratio of 10.91. The stock has a market capitalization of $3.61 billion, a PE ratio of 24.30, a price-to-earnings-growth ratio of 3.75 and a beta of 0.73. The company has a 50 day moving average price of $71.61 and a two-hundred day moving average price of $72.34. National Health Investors has a 1 year low of $65.13 and a 1 year high of $86.13.

National Health Investors (NYSE:NHI - Get Free Report) last posted its quarterly earnings data on Wednesday, August 6th. The real estate investment trust reported $1.22 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.16 by $0.06. National Health Investors had a net margin of 40.97% and a return on equity of 10.32%. The firm had revenue of $70.27 million for the quarter, compared to the consensus estimate of $86.46 million. During the same period in the previous year, the firm earned $1.18 EPS. The business's revenue for the quarter was up 6.7% compared to the same quarter last year. As a group, research analysts anticipate that National Health Investors will post 4.41 EPS for the current year.

National Health Investors Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be issued a $0.92 dividend. The ex-dividend date of this dividend is Tuesday, September 30th. This is a positive change from National Health Investors's previous quarterly dividend of $0.90. This represents a $3.68 dividend on an annualized basis and a dividend yield of 4.8%. National Health Investors's payout ratio is currently 117.57%.

Institutional Investors Weigh In On National Health Investors

A number of institutional investors and hedge funds have recently modified their holdings of NHI. LPL Financial LLC lifted its holdings in shares of National Health Investors by 2.0% in the fourth quarter. LPL Financial LLC now owns 22,842 shares of the real estate investment trust's stock worth $1,583,000 after buying an additional 449 shares in the last quarter. Wells Fargo & Company MN increased its position in shares of National Health Investors by 8.3% in the fourth quarter. Wells Fargo & Company MN now owns 76,072 shares of the real estate investment trust's stock worth $5,272,000 after purchasing an additional 5,853 shares during the last quarter. Raymond James Financial Inc. bought a new position in shares of National Health Investors in the fourth quarter worth approximately $2,219,000. Sterling Capital Management LLC increased its position in shares of National Health Investors by 61.1% in the fourth quarter. Sterling Capital Management LLC now owns 3,099 shares of the real estate investment trust's stock worth $215,000 after purchasing an additional 1,175 shares during the last quarter. Finally, Barclays PLC increased its position in shares of National Health Investors by 7.6% in the fourth quarter. Barclays PLC now owns 77,122 shares of the real estate investment trust's stock worth $5,344,000 after purchasing an additional 5,419 shares during the last quarter. 62.51% of the stock is owned by hedge funds and other institutional investors.

About National Health Investors

(Get Free Report)

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

See Also

Analyst Recommendations for National Health Investors (NYSE:NHI)

Should You Invest $1,000 in National Health Investors Right Now?

Before you consider National Health Investors, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.

While National Health Investors currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Follow the Money: 5 Stocks Institutions Are Buying NOW
Palantir’s Soaring Valuation—Justified or Overhyped?
3 Stocks With Explosive Upside

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines